Anti-IgE therapy for peanut allergy clearly remains a therapy that warrants further study and might find a role as adjunct or supplemental therapy in combination with peanut OIT, and studies are ...
Methods: MEDLINE, In-Process & Other Non-Indexed Citations, and EMBASE Drugs & Pharmacology were searched using olizumab, omalizumab, E25, rhuMAb-E25, and anti-IgE. Combinations of rhinitis ...
The following is a summary of “Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study,” ...
The agreement grants RAPT global rights, excluding Hong Kong, Taiwan, Macau, and mainland China, to develop and commercialise the therapy ... Jemincare sign anti-IgE antibody agreement" was ...
In addition to these findings, the use of omalizumab, an anti-IgE therapy, has also been explored in treating Morbihan syndrome, particularly in an adolescent girl who did not respond to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results